MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2025 Earnings Call Transcript May 15, 2025
Operator: Thank you for standing by. My name is Rochelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the MiNK Therapeutics First Quarter 2025 Financial Results. After the speaker remarks, there will be a question-and-answer session. [Operator Instructions] I will now turn the conference call Jennifer Buell [ph], Head of Investor Relations. Please go...
